ahlam1399
07-13-2016, 05:06 AM
FDA expands use of Pfizer?s best-selling pneumonia vaccine
(Reuters) - Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=QhDqnIdLRpw:R6ZsaPsU6Js:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=QhDqnIdLRpw:R6ZsaPsU6Js:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/QhDqnIdLRpw
(Reuters) - Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=QhDqnIdLRpw:R6ZsaPsU6Js:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=QhDqnIdLRpw:R6ZsaPsU6Js:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=QhDqnIdLRpw:R6ZsaPsU6Js:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/QhDqnIdLRpw